Age-related macular degeneration damages the macula — the retina's high-resolution center — blurring or distorting central vision while peripheral vision survives. The dry form progresses slowly through drusen deposits toward atrophy; the wet form, where fragile new vessels leak under the retina, can destroy central vision in weeks but responds to anti-VEGF injections. The AREDS2 formula (vitamins C and E, zinc, copper, lutein, zeaxanthin) reduces progression risk by about 25% in people with intermediate AMD — and does not prevent AMD in healthy eyes. Smoking is the biggest modifiable risk. Sudden distortion — straight lines bending — is an urgent-care symptom.
What AMD is
The macula is the few square millimeters of retina responsible for everything demanding — reading, faces, screens, thread-the-needle vision. Age-related macular degeneration is the gradual failure of its support system: the pigment layer and membrane that feed and clean the photoreceptors accumulate waste (drusen — the yellow deposits an eye exam sees years before symptoms), thin, and eventually atrophy or provoke destructive repair.
It is the leading cause of severe vision loss in older adults in wealthy countries — roughly 1 in 8 people over 60 have some stage — and its two forms behave like different diseases:
- Dry (atrophic) AMD — ~85–90% of cases: drusen accumulate, pigment disturbs, and over years patches of retina waste away (geographic atrophy at the late stage). Slow, but capable of serious central loss.
- Wet (neovascular) AMD — the minority that causes most rapid blindness: abnormal vessels grow beneath the retina and leak fluid and blood. Untreated, central vision can scar within weeks; treated promptly, it is largely controllable.
Any dry AMD can convert to wet at any time — the fact that organizes home monitoring.
Symptoms and self-checks
Early AMD is symptom-free (found on exam). As it advances: blur at the center of gaze, need for brighter light, slow dark adaptation, faded colors, and the signature — metamorphopsia, straight lines bending. The Amsler grid is the weekly self-check for anyone diagnosed; new distortion or a central smudge is a days-not-weeks appointment, because wet-AMD outcomes track speed of treatment.
Floaters, note, are a different symptom with their own emergency rules.
Risk factors
Age dominates. After it: smoking (2–4× risk — the strongest modifiable factor, and quitting helps at any stage), family history and genetics (complement-pathway variants), cardiovascular risk factors, obesity, extensive sun exposure (plausible, protective habits cheap), and a diet poor in the leafy greens and fish that supply the macula's own pigments — the biology behind lutein and zeaxanthin.
The AREDS story — precisely
The Age-Related Eye Disease Studies (AREDS, then AREDS2 — NEI-run randomized trials in thousands of participants) are the reason this site can say a supplement formula works for something:
- Who benefits: people with intermediate AMD (large drusen) or advanced AMD in one eye. In them, the formula cut the risk of progressing to advanced AMD by ~25% over five years, and AREDS2's refinement (beta-carotene out — it raised lung-cancer risk in smokers — lutein 10 mg + zeaxanthin 2 mg in; zinc 80 mg, vitamin C 500 mg, vitamin E 400 IU, copper) became the standard.
- Who does not: healthy eyes and early AMD saw no preventive benefit, and neither trial helped cataract. The formula slows an established disease; it is not eye insurance.
Every departure from that sentence — "vision support" blends at half-doses, formulas for the healthy, lutein sold as prevention — is marketing arbitrage on AREDS's reputation, measured against the actual evidence in Do eye vitamins work?
Treatment by form
Dry AMD: AREDS2 for qualifying stages; smoking cessation; the Mediterranean-pattern diet associated with slower progression (greens, fish, nuts); Amsler monitoring; low-vision rehabilitation when needed — magnification, lighting, contrast tools that preserve function impressively. New drugs for late geographic atrophy (complement inhibitors) exist with modest effects — a specialist conversation.
Wet AMD: anti-VEGF injections (per the FAQ) — one of modern medicine's genuine turnarounds: legal blindness from wet AMD has fallen steeply where treatment is available. Urgency is the patient's contribution: distortion today, retina clinic this week.
Both: treat the whole vasculature — blood pressure, lipids, diabetes — and keep the untouched eye monitored, since second eyes carry high risk.
When to seek care
Routine dilated exams from 50 (earlier with family history) — AMD's early years are visible only to an ophthalmoscope. Urgent (days): new central distortion, a fresh central blur or smudge, or a rapid change on the Amsler grid, in either eye, diagnosed or not. Emergency-adjacent: sudden central loss. And permanently: any smoker with a family history of AMD holds the single most effective prescription in this article — stopping.
Frequently asked questions
What does AMD vision loss actually look like?
Not blackness — a smudge, blur or distortion parked at the center of gaze: faces hard to recognize while the person's outline is clear, print that swims, straight door frames that bow. Peripheral vision persists, which preserves mobility; reading and faces suffer first. Distortion appearing or worsening quickly is the urgent sign.
What is the Amsler grid?
A square of graph paper with a center dot — stare at the dot one eye at a time and note any lines that bend, blur or vanish. It is the standard home monitor for people with diagnosed AMD, checked weekly, because wet conversion announces itself as new distortion, and injection outcomes are best when treatment starts within days.
Should everyone over 50 take AREDS2 vitamins?
No — that is the aisle's favorite over-reading. AREDS tested people who already had intermediate AMD (or advanced in one eye) and found ~25% relative reduction in progression; the same research found no benefit preventing AMD in unaffected eyes, and no effect on cataract. The formula is condition-specific medicine, prescribed off an eye exam, not a general-population vitamin.
Is wet AMD curable now?
Controllable, dramatically. Anti-VEGF injections (given into the numbed eye — routine, quick, far less awful than it sounds) stop the leaking vessels, preserve vision in the large majority and improve it in a substantial minority, on schedules that often stretch out over time. The catch is permanence of commitment: stopping usually reactivates disease, and vision already scarred does not return — hence the premium on catching conversion early.
References
- National Eye Institute. Age-Related Macular Degeneration (AMD) (2024). https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration
- JAMA. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial (2013). PubMed PMID 23644932. https://pubmed.ncbi.nlm.nih.gov/23644932/
This page contains no product recommendations or affiliate links. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.